Physician profile
Christopher Jimenez
NPI 1700013398
$71,511.90
in general payments reported to CMS, 2019-2025
39 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $14K · 2021: $4,125 · 2022: $6,463 · 2023: $3,426 · 2024: $17K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $5,115 · Travel and Lodging: $3,722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,246.26 |
| Food and Beverage | $5,115.44 |
| Travel and Lodging | $3,722.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $57,644.65 | 2019-2025 | Actis, Velys, Attune |
| Stryker Corporation | $2,661.82 | 2019-2025 | Mako, Inspace |
| Arthrex, INC. | $2,387.00 | 2019 | |
| Medacta USA, INC. | $2,006.18 | 2023 | Amistem, Gmk Sphere, Mpact |
| Zimmer Biomet Holdings, INC. | $1,698.76 | 2020-2025 | Persona, Comprehensive Shoulder System, Rosa |
| Depuy Synthes Sales INC. | $1,399.05 | 2019-2025 | Velys, Attune, Kincise |
| Curonix LLC | $756.97 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medinc of Texas | $506.55 | 2019 | |
| Abbott Laboratories | $323.01 | 2019-2025 | Proclaim, Octrode |
| Innovation Technologies INC | $313.46 | 2022-2025 | Irrisept |
| Foundation Fusion Solutions, LLC | $240.77 | 2021-2022 | |
| Medtronic, INC. | $206.78 | 2023 | Signia, Intellis Adaptivestim |
| Orthalign INC | $153.59 | 2020-2021 | |
| Boston Scientific Corporation | $131.42 | 2022 | |
| Davol INC. | $129.16 | 2025 | Arista |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $119.95 | 2025 | Zynrelef |
| Intuitive Surgical, INC. | $88.58 | 2023 | Da Vinci Surgical System |
| Bioventus LLC | $80.36 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $71.37 | 2020-2021 | |
| Baxter Healthcare | $70.67 | 2019-2021 | |
| Integra Lifesciences Corporation | $52.06 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Becton, Dickinson and Company | $47.46 | 2022-2025 | Arista Ah Flexitip, Surgiphor |
| Corium, LLC | $42.40 | 2023 | Adlarity |
| Restor3d, INC. | $41.58 | 2025 | |
| Ermi LLC | $41.46 | 2023-2024 | |
| Smith+Nephew, INC. | $38.95 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $37.33 | 2022 | |
| Core Surgical Group | $25.64 | 2023 | |
| Kci USA, INC. | $23.73 | 2023 | Prevena |
| Si-Bone, INC. | $22.41 | 2025 | |
| Avanos Medical | $21.07 | 2019 | |
| Orthofix Medical, INC. | $19.50 | 2019-2020 | |
| Convatec INC. | $19.48 | 2023 | |
| Fidia Pharma USA INC. | $19.02 | 2025 | Hymovis, Triluron |
| Pacira Pharmaceuticals Incorporated | $18.88 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.14 | 2022 | |
| Orthogenrx INC. | $14.31 | 2019 | |
| Arthrosurface Incorporated | $12.25 | 2019 | |
| Orthosensor INC. | $9.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.